Resources

Infertility Treatment Market

Future Market Insights

Provides information on global infertility treatment market size, growth forecasts, key segments, regional trends, leading companies, and technological advancements for strategic decision-making.

Iron and Folic Acid Supplementation in Pregnancy: Findings from the Baseline Assessment of a Maternal Nutrition Service Programme in Bangladesh

Billah et al.

Provides data on iron and folic acid supplementation coverage, adherence, and influencing factors among pregnant women in rural Bangladesh to inform program improvements.

Landscape of Diagnostics Development for Preterm Labour, Pre-eclampsia & Intrauterine Growth Restriction

Impact Global Health

Summarizes the global development pipeline and status of diagnostics for preterm labour, preeclampsia, and intrauterine growth restriction to guide R&D priorities.

Market Failure and the Poverty of New Drugs in Maternal Health

Fisk, N. M. & Atun, R. 

Summarizes the lack of pharmaceutical R&D for maternal health, reviews causes, and discusses implications for global health policy and drug development priorities.

Maternal health pipeline

Impact Global Health

Profiles and tracks medicines, diagnostics, and devices for seven major pregnancy-related conditions to inform maternal health R&D investment and development decisions.

Medical Treatments for Incomplete Miscarriage

Kim, C. et al.

Summarizes evidence on effectiveness, safety, and acceptability of medical treatments versus surgery or expectant care for incomplete miscarriage before 24 weeks.

Medication Use in Pregnancy: A Cross-Sectional, Multinational Web-Based Study

Lupattelli, A. et al.

Provides information on patterns, prevalence, and factors associated with medication and over-the-counter drug use during pregnancy across multiple countries.

Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper

Panay et al.

Summarizes key controversies and evidence on menopause and hormone therapy to guide clinicians and women in making ethical, individualized care decisions.

National Policy Influences of Contraceptive Prevalence and Method Mix Strategy: A Longitudinal Analysis of 59 Low- and Middle-Income Countries, 2010–2021

Cohen et al.

Summarizes national policies linked to contraceptive prevalence and method mix in 59 low- and middle-income countries to guide effective family planning strategies.

Neglected medium-term and long-term consequences of labour and childbirth: a systematic analysis of the burden, recommended practices, and a way forward

Vogel

Summarizes the burden, prevalence, and guidelines for neglected medium- and long-term maternal complications after childbirth to inform care and policy improvements.

New Evidence to Guide Ectopic Pregnancy Diagnosis and Management

Brady P. C. 

Reviews recent evidence on ectopic pregnancy risk factors, diagnosis, and management to guide clinical decision-making for obstetricians and gynecologists.

NIH-wide Strategic Plan For Research On The Health Of Women

NIH

Summarizes NIH’s strategic goals, priorities, and approaches for advancing women’s health research to guide research, policy, and workforce development.

Organoid modeling meets cancers of female reproductive tract.

Li et al.

Reviews organoid models for female reproductive tract cancers, summarizing construction methods, research advances, limitations, and future applications in personalized medicine and drug development.

Pessary Use in Pelvic Organ Prolapse and Urinary Incontinence

Jones, K. A. & Harmanli, O. 

Provides information on pessary types, indications, fitting, maintenance, and complications for managing pelvic organ prolapse and urinary incontinence.

R&D funding landscape for endometriosis

Impact Global Health

Summarizes global R&D funding, diagnostic and treatment pipelines, and unmet needs for endometriosis to inform research, policy, and investment decisions.

R&D funding landscape for menopause

Impact Global Health

Summarizes menopause R&D needs, current treatments, funding data, and innovation gaps to inform funders, policymakers, and advocates on advancing menopause care and research.

Reproductive Health Impact Study

Guttmacher

Provides data and analysis on how federal and state policy changes affect US publicly funded family planning care, aiming to inform policy and improve reproductive health equity.

Research & Development Landscape for Maternal Enteric Microbiome Medicines (2000-2023)

Impact Global Health

Summarizes global research and development trends for maternal enteric microbiome medicines (2000-2023) to guide future maternal and neonatal health interventions.

Research & Development Landscape for Maternal Iron Deficiency Anaemia Medicines (2000-2023)

Impact Global Health

Reviews research and development data on maternal iron deficiency anaemia medicines (2000-2023) to inform innovation, policy decisions, and future investment priorities.

Research advances in the construction of stem cell-derived ovarian organoids

Zhang et al.

Reviews advances in constructing stem cell-derived ovarian organoids, summarizing methods, challenges, and applications for reproductive medicine and fertility preservation.

Small Vulnerable Newborn Series

The Lancet

Summarizes prevalence, risks, mechanisms, and prevention strategies for small vulnerable newborns to inform global health action and improve outcomes.

Snapshot of the R&D Landscape for Pre-eclampsia

Impact Global Health

Summarizes the current R&D landscape for pre-eclampsia, including medicines, diagnostics, funding, and innovation priorities, to inform research, policy, and advocacy decisions.

Snapshot of the R&D landscape of postpartum haemorrhage devices (2000-2023)

Impact Global Health

Summarizes the R&D landscape, pipeline status, and types of postpartum haemorrhage devices from 2000-2023 to inform innovation and investment decisions.

The Direct and Indirect Costs Associated with Endometriosis: A Systematic Literature Review

Soliman, A. M. et al.

Summarizes direct and indirect costs of endometriosis worldwide to inform understanding of its economic burden for healthcare planning and policy.